Literature DB >> 17948281

Divergent backward masking performance in schizophrenia and bipolar disorder: association with COMT.

Vina M Goghari1, Scott R Sponheim.   

Abstract

Schizophrenia has been reliably associated with impairments in backward masking performance, while bipolar disorder has less consistently been tied to such a deficit. To examine the genetic determinants of visual perception abnormalities in schizophrenia and bipolar disorder, this study evaluated the diagnostic specificity of backward masking performance deficits and whether masking deficits were associated with catechol-O-methyl transferase (COMT) genotype. A location-based backward masking task, which equated participants on the perceptual intensity of stimuli, was completed by 41 schizophrenia outpatients, 28 bipolar outpatients, and 43 nonpsychiatric controls. COMT genotype data were available for 39 schizophrenia outpatients, 28 bipolar outpatients, and 20 nonpsychiatric controls. Schizophrenia patients demonstrated impaired backward masking performance compared to controls and bipolar patients. A group by COMT genotype interaction was detected with schizophrenia Met homozygotes performing more poorly than control and bipolar Met homozygotes, and worse than Val homozygote and heterozygote schizophrenia patients. This study provides novel evidence for differential effects of the COMT gene on neural systems underlying visual perception in schizophrenia and bipolar disorder. The COMT Met allele may be associated with deficits in schizophrenia that are unrelated to neural systems supporting sustained attention or working memory. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17948281     DOI: 10.1002/ajmg.b.30583

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  8 in total

1.  Reduced contextual effects on visual contrast perception in schizophrenia and bipolar affective disorder.

Authors:  M-P Schallmo; S R Sponheim; C A Olman
Journal:  Psychol Med       Date:  2015-08-28       Impact factor: 7.723

2.  Fragile early visual percepts mark genetic liability specific to schizophrenia.

Authors:  Scott R Sponheim; Sarah M Sass; Althea L Noukki; Bridget M Hegeman
Journal:  Schizophr Bull       Date:  2012-03-23       Impact factor: 9.306

3.  Disruption of Conscious Access in Psychosis Is Associated with Altered Structural Brain Connectivity.

Authors:  Lucie Berkovitch; Lucie Charles; Antoine Del Cul; Nora Hamdani; Marine Delavest; Samuel Sarrazin; Jean-François Mangin; Pamela Guevara; Ellen Ji; Marc-Antoine d'Albis; Raphaël Gaillard; Frank Bellivier; Cyril Poupon; Marion Leboyer; Ryad Tamouza; Stanislas Dehaene; Josselin Houenou
Journal:  J Neurosci       Date:  2020-11-23       Impact factor: 6.167

Review 4.  Visual masking in schizophrenia: overview and theoretical implications.

Authors:  Michael F Green; Junghee Lee; Jonathan K Wynn; Kristopher I Mathis
Journal:  Schizophr Bull       Date:  2011-05-23       Impact factor: 9.306

5.  Cross-diagnostic comparison of visual processing in bipolar disorder and schizophrenia.

Authors:  Carol Jahshan; Jonathan K Wynn; Amanda McCleery; David C Glahn; Lori L Altshuler; Michael F Green
Journal:  J Psychiatr Res       Date:  2014-01-02       Impact factor: 4.791

6.  Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder.

Authors:  Vina M Goghari; Scott R Sponheim
Journal:  Schizophr Res       Date:  2008-06-20       Impact factor: 4.939

7.  Association of the Nicotinic Receptor α7 Subunit Gene (CHRNA7) with Schizophrenia and Visual Backward Masking.

Authors:  George Bakanidze; Maya Roinishvili; Eka Chkonia; Werner Kitzrow; Sarina Richter; Konrad Neumann; Michael H Herzog; Andreas Brand; Imke Puls
Journal:  Front Psychiatry       Date:  2013-10-22       Impact factor: 4.157

8.  Perceptual Mechanisms of Visual Hallucinations and Illusions in Psychosis.

Authors:  Samuel D Klein; Cheryl A Olman; Scott R Sponheim
Journal:  J Psychiatr Brain Sci       Date:  2020-08-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.